Literature DB >> 19756596

Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.

Rebecca Liu1, Duane A Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19756596     DOI： 10.1007/s00262-009-0757-9

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  9 in total

1.  Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.

Authors:  Smita K Nair; Timothy Driscoll; David Boczkowski; Robert Schmittling; Renee Reynolds; Laura A Johnson; Gerald Grant; Herbert Fuchs; Darell D Bigner; John H Sampson; Sridharan Gururangan; Duane A Mitchell
Journal:  J Neurooncol       Date:  2015-08-27       Impact factor: 4.130

Review 2.  Vaccination strategies for neuro-oncology.

Authors:  John H Sampson; Duane A Mitchell
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 3.  Quo Vadis-Do Immunotherapies Have a Role in Glioblastoma?

Authors:  Sylvia C Kurz; Patrick Y Wen
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

4.  Survivin expression in medulloblastoma: a possible marker for survival.

Authors:  Azza Abdel-Aziz; Mie Ali Ali Mohamed; Fatma Mohamed Farouk Akl; Ahmed Nageeb M Taha
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

Review 5.  Advances and challenges: dendritic cell vaccination strategies for glioblastoma.

Authors:  Teilo H Schaller; John H Sampson
Journal:  Expert Rev Vaccines       Date:  2016-08-10       Impact factor: 5.217

6.  Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.

Authors:  Young-Hee Kim; Thi-Anh-Thuy Tran; Hyun-Ju Lee; Sook-In Jung; Je-Jung Lee; Wool-Youl Jang; Kyung-Sub Moon; In-Young Kim; Shin Jung; Tae-Young Jung
Journal:  Oncotarget       Date:  2016-08-02

Review 7.  Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas.

Authors:  Jean Philippe Nesseler; Dorthe Schaue; William H McBride; Mi-Heon Lee; Tania Kaprealian; Simone P Niclou; Philippe Nickers
Journal:  Adv Radiat Oncol       Date:  2018-11-20

Review 8.  Impact of General Factors on Glioma Immunotherapy.

Authors:  Qilin Huang; Dongmei Wang; Guojie Yao; Hongxiang Wang
Journal:  J Clin Neurol       Date:  2022-01       Impact factor: 3.077

Review 9.  T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges.

Authors:  Dalia Haydar; Jorge Ibañez-Vega; Giedre Krenciute
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.